Method for treating melanocortin 4 receptor-associated disorders in heterozygous carriers

• 收藏
• 分享

专利权人:

Rhythm Pharmaceuticals; Inc.

发明人:

TARTAGLIA, Louis, A.,HENDERSON, Bart

申请号：

DK12863862

公开号：

DK2797615T3

申请日:

2012.12.28

申请国别(地区):

DK

年份:

2019

代理人:

摘要：

A method of treating a disorder in a subject. The method comprises administering to said subject an effective amount of an agonist of the melanocortin-4 receptor (MC4R). The subject is a heterozygous carrier of an MC4R mutation, and the disorder results from an attenuated response of MC4R to α-melanocortin stimulating hormone (α-MSH).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/